中国综合临床
中國綜閤臨床
중국종합림상
CLINICAL MEDICINE OF CHINA
2008年
9期
901-902
,共2页
童小文%张春炳%朱纲%方萍%周龙女
童小文%張春炳%硃綱%方萍%週龍女
동소문%장춘병%주강%방평%주룡녀
急性脑出血%人血白蛋白%临床疗效
急性腦齣血%人血白蛋白%臨床療效
급성뇌출혈%인혈백단백%림상료효
Acute cerebral hemorrhage%Human blood albumin%Effect
目的 探讨人血白蛋白治疗急性脑出血的临床疗效及安全性. 方法 急性脑出血患者88例随机分为对照组和治疗组,治疗组在常规治疗基础上加用10%人血白蛋白100 ml静脉滴注,1次/d,连用7d.14 d为一疗程.比较神经功能缺损程度评分变化. 结果 治疗组总有效率及神经功能缺损评分改善情况均优于对照组(P<0.05),治疗过程中无不良反应发生. 结论 人血白蛋白治疗急性脑出血临床疗效确切、安全.
目的 探討人血白蛋白治療急性腦齣血的臨床療效及安全性. 方法 急性腦齣血患者88例隨機分為對照組和治療組,治療組在常規治療基礎上加用10%人血白蛋白100 ml靜脈滴註,1次/d,連用7d.14 d為一療程.比較神經功能缺損程度評分變化. 結果 治療組總有效率及神經功能缺損評分改善情況均優于對照組(P<0.05),治療過程中無不良反應髮生. 結論 人血白蛋白治療急性腦齣血臨床療效確切、安全.
목적 탐토인혈백단백치료급성뇌출혈적림상료효급안전성. 방법 급성뇌출혈환자88례수궤분위대조조화치료조,치료조재상규치료기출상가용10%인혈백단백100 ml정맥적주,1차/d,련용7d.14 d위일료정.비교신경공능결손정도평분변화. 결과 치료조총유효솔급신경공능결손평분개선정황균우우대조조(P<0.05),치료과정중무불량반응발생. 결론 인혈백단백치료급성뇌출혈림상료효학절、안전.
Objective To assess the clinical effect and safety of human blood albumin in treatment of acute cerebral hemorrhage.Methods 88 patients with acute cerebral hemorrhage were randomly divided into 2 groups. Both group were given routine therapy and 45 cases in the treating group were given additional 10% human blood albumin 100 ml ivgtt once a day for 7 days.14 days served as a treatment course.Neurofunction was compared before and after treatment.Results Both the effective rate (P<0.05) and the neurofunction in the treating group were better than that of the control group (P<0.05).No advert effect happened.Conclusion Human blood albumin is an efiective and safe medicine for treatment of acute cerebral infarction.
